Attachments
CreditFlow € £ & Chf Supply Analysis (Europe IG)_2026-11-19.xlsx
CreditFlow Recent € £ Chf & Reg S $ Supply Table (Europe IG).xlsx
Related Deals
Related Parents
by Anna Tkachenko
Nov 19, 2026 11:32 AM ET
Corp: Highlights
FIG: Highlights
SSA: Highlights
Contact Stuart Aylward with questions or comments on Bloomberg or via stuart@creditflowresearch.com
Euro IG (today)
Type | Issuer | Size (m) | Structure | Initial Pricing | Final Spd / Yield | IPT to PX | NIC (bp) | Books (m) | Cover 'X' |
Corp | American Medical Systems Europe | €500 | 2yr FRN | 3mth € +85 to +90 | 3mth € +63 | -24.5 | 8 | €1,400 | 2.80 X |
Corp | American Medical Systems Europe | €500 | 2yr | MS+75 to +80 | MS+53 | -24.5 | 8 | €1,600 | 3.20 X |
Corp | American Medical Systems Europe | €750 | 4yr | MS+105 area | MS+75 | -30 | 5 | €2,200 | 2.93 X |
Corp | American Medical Systems Europe | €750 | 8yr | MS+135 to +140 | MS+110 | -27.5 | 5 | €2,500 | 3.33 X |
Corp | American Medical Systems Europe | €1,000 | 12yr | MS+160 to +165 | MS+135 | -27.5 | 10 | €2,600 | 2.60 X |
Corp | American Medical Systems Europe | €750 | 20yr | MS+200 area | MS+170 | -30 | 10 | €1,700 | 2.27 X |
Corp | Teollisuuden Voima Oyj | €500 | 5.25yr EuGB | MS+135 area | MS+105 | -30 | 5 | €1,350 | 2.70 X |
Type | Issuer | Size (m) | Structure | Initial Pricing | Final Spd / Yield | IPT to PX | NIC (bp) | Books (m) | Cover 'X' |
FIG | Rabobank | €1,500 | 3yr EuGB Covered | MS+16 area | MS+10 | -6 | 1 | €2,250 | 1.50 X |
FIG | Banca Sella SpA | €400 | Long 4yr Covered | MS+47 area | MS+43 | -4 | 8 | €400 | 1.00 X |
FIG | Danske Bank | €500 | 2yr FRN Snr Pref | 3mth €+75 area | 3mth €+47 | -28 | 7 | €2,400 | 4.80 X |
FIG | Danske Bank | €650 | 5NC4 Snr Pref | MS+95 area | MS+65 | -30 | 10 | €1,600 | 2.46 X |
FIG | S-Bank Plc | €150 | 4NC3 FRN Snr Non-Pref | 3mth €+155 area | 3mth €+130 | -25 | - | €320 | 2.13 X |
Type | Issuer | Size (m) | Structure | Initial Pricing | Final Spd / Yield | IPT to PX | NIC (bp) | Books (m) | Cover 'X' |
SSA | Auckland Council | €500 | 6yr Green Snr Sec | MS+40 area | MS+36 | -4 | - | €2,250 | 4.50 X |
Week-to-date volumes:
Year-to-date volumes:
Sterling IG (today)
Week-to-date volumes:
Year-to-date volumes:
Swiss Franc IG (today)
Type | Issuer | Size (m) | Structure | Initial Pricing | Final Spd / Yield | IPT to PX |
Corp | Grand City Properties | Chf 125 | 5yr | SARON MS+160 to +170 | SARON MS+170 | 5 |
Week-to-date volumes:
US$ Reg S (today)
Transaction Details
IGC European Market: Deal Flow - General
Issuer | Term | Coupon | Maturity | Size | Ranking | Type | Price | Yield | Guidance | Spread | GDNC-PXD |
|---|---|---|---|---|---|---|---|---|---|---|---|
Grand City Properties | 5yr | 2.305% | 3-Dec-31 | CHF 125m | Sr Unsec | Fixed | 100 | 2.305% | SARON MS+160/170 | SARON MS+170 | +5 |
Reoffer: 5yr: SARON MS+170bp / 100 / 2.305%
Benchmark: 5yr: Govt.+179bp
Launched: 5yr: CHF 125m @ SARON MS+170bp
Guidance: 5yr: SARON MS+160/170bp
IGC European Market: Deal Flow - General
Issuer | Term | Coupon | Maturity | Size | Ranking | Type | Price | Yield | Guidance | Spread | GDNC-PXD |
|---|---|---|---|---|---|---|---|---|---|---|---|
Rabobank | 3yr | 3.530% | 26-Nov-29 | €1.5bn | CB | Fixed | 100 | 3.530% | MS+16a | MS+10 | -6 |
Reoffer: 3yr: MS+10bp / 100 / 3.530%
Benchmark: 3yr: OBL 2.5% Oct-29 @ 98.141 / B+34.6bp (HR 104%)
Final Books: In excess of €2.25bn (including €200m JLM). Peak book in excess of €2.4bn (including €200m JLM)
Launched: 3yr: €1.5bn @ MS+10bp - Books in excess of €2.4bn (including €200m JLM)
Spread set at: 3yr: MS+10bp - Books in excess of €2.4bn (including €200m JLM)
Book Update: Books in excess of €2.25bn (including €200m JLM)
Guidance: 3yr: MS+16a
Covered EuGB
3yr (Nov 2029) @ MS+16a
Implied Spread for fresh 3yr @ MS+9
Priced at MS+10
NIC of +1
Comps | |||||||
TICKER | CPN | ISSUE DATE | MATURITY | Tenor | SIZE | Mid I-spd | ESG |
MUNHYP | 2.875 | 16/06/2026 | 05/07/2029 | 2.6yr | 625 | 3 | N |
BYLAN | 2.75 | 22/06/2026 | 22/06/2029 | 2.6yr | 500 | 5 | N |
MUNHYP | 3.5 | 23/11/2026 | 23/11/2029 | 3.0yr | 500 | 6 | Y |
IGC European Market: Deal Flow - General
Issuer | Term | Coupon | Maturity | Size | Ranking | Type | Price | Yield | Spread | IPT-PXD |
|---|---|---|---|---|---|---|---|---|---|---|
Banca Sella | Long 4yr | 3.750% | 26-Jan-31 | €400m | CB | Fixed to Floating | 99.608 | 3.850% | MS+43 | -4 |
Reoffer: Long 4yr: MS+43bp / 99.608 / 3.850%
Benchmark: Long 4yr: OBL 2.2 10-Oct-30 @ 96.375 / B+64.2bp / HR 108%
Tranche 1 (Long 4yr): Final Books above €400m. Peak book above €650m (excl JLMs)
Launched: Long 4yr: €400m @ MS+43bp - Books above €650m (excl JLMs)
Spread set at: Long 4yr: MS+43bp
IPTs: Long 4yr: MS+47a
Covered
L 4yr (Jan 2031) @ MS+47a
Implied Spread for fresh L 4yr @ MS+35
Priced at MS+43
NIC of +8
IGC European Market: Deal Flow - SSA
Issuer | Term | Coupon | Maturity | Size | Ranking | Type | ISIN | Price | Yield | Spread | IPT-PXD |
|---|---|---|---|---|---|---|---|---|---|---|---|
Auckland Council | 6yr | 3.75% | 30-Nov-32 | €500m | Snr Sec | Fixed | XS3567713030 | 99.868 | 3.775% | MS+36 | -4 |
Reoffer: 6yr: MS+36bp / 99.868 / 3.775%
Tranche 1 (6yr): Peak book in excess of €2.25bn (excl JLM)
Launched: 6yr: €500m @ MS+36bp - Books in excess of €2.25bn (excl JLM)
IPTs: 6yr: MS+40a
IGC European Market: Deal Flow - General
Issuer | Term | Coupon | Maturity | Size | Ranking | Type | Price | Yield | Spread | IPT-PXD | ISIN |
|---|---|---|---|---|---|---|---|---|---|---|---|
Teollisuuden Voima Oyj | 5.25yr | 4.375% | 26-Feb-32 | €500m | Sr Unsec | Fixed | 99.568 | 4.473% | MS+105 | -30 | XS3579992515 |
Reoffer: 5.25yr: MS+105bp / 99.568 / 4.473%
Benchmark: 5.25yr: DBR 0 15-Feb-32 @ 84.64 / B+123.3bp (HR: 107%)
Final Books: >€1.35bn. Peak book >€1.7bn (pre-rec)
Launched: 5.25yr: €500m @ MS+105bp
IPTs: 5.25yr: MS+135a
5.25yr (Feb 2032) @ MS+135a
Implied Spread for fresh 5.25yr @ MS+100
Priced at MS+105
NIC of +5
COMPS | ||||||||
Issuer | M/S/F | ESG | Cpn (%) | Out. (€m) | Issue | Maturity | YTM | Sprd |
Teollisuuden Voima Oyj | Baa3/NR/BBB- | - | 4.75 | 600 | May-23 | Jun-30 | 3.5y | 86 |
Teollisuuden Voima Oyj | Baa3/NR/BBB- | Green | 4.25 | 600 | May-24 | May-31 | 4.5y | 88 |
Teollisuuden Voima Oyj | Baa3/-/BBB- | Green | 3.625 | 500 | Sep-25 | Mar-33 | 6.3y | 109 |
IGC European Market: Deal Flow - General
Issuer | Term | Call | Coupon | Maturity | Size | Ranking | Type | Price | Yield | Spread | IPT-PXD |
|---|---|---|---|---|---|---|---|---|---|---|---|
Danske Bank | 2y | - | 3mE+47bp | 27-Nov-28 | €500m | SP | Floating | 100 | - | 3mE+47 | -28 |
Danske Bank | 5NC4 | 4y | 4.000% | 27-Nov-31 | €650m | SP | Fixed Rate Reset | 99.685 | 4.087% | MS+65 | -30 |
Reoffer: 2y: 3mE+47bp / 100 5NC4: MS+65bp / 99.685 / 4.087%
Benchmark: 5NC4: OBL 2.2 30 #192 @ 96.316 / B+86.3bp / HR 103%
Tranche 1 (2y FRN): Final Books above €2.4bn. Peak book above €3.3bn
Tranche 2 (5NC4 FXD): Final Books above €1.6bn. Peak book above €2.3bn
Launched:
2y: €500m @ 3mE+47bp - Books above €3.3bn (Combined books above €5.6bn ex JLMs)
5NC4: €650m @ MS+65bp - Books above €2.3bn
Book Update: Books above €4.0bn (Ex JLM's)
IPTs: 2y: 3mE+75a 5NC4: MS+95a
Senior Preferred
2yr (Nov 2029) @ 3mE+75a
Implied Spread for fresh 2yr @ 3mE+40
Priced at 3mE+47
NIC of +7
Senior Preferred
NC4yr (May 2030) @ MS+95a
Implied Spread for fresh NC4yr @ MS+55
Priced at MS+65
NIC of +10
COMPS | ||||||||
Ticker | Rating (M/S&P/F) | CPN | Size (m) | Mat | Call dt | Life | I-sprd | CPN |
DANBNK | A1/A+/AA | 4,125 | 1000 | Jan-31 | Jan-30 | 3,1 | 56 | FXD |
DANBNK | A1/A+/AA | 3,250 | 750 | Jan-33 | Jan-32 | 5,2 | 66 | FXD |
DNBNO | Aa2/AA-/- | 3,000 | 750 | Jan-32 | Jan-31 | 4,2 | 59 | FXD |
SHBASS | Aa2/AA-/AA+ | 3,875 | 750 | Oct-30 | Bullet | 3,9 | 46 | FXD |
NDAFH | Aa3/AA-/AA | 3,250 | 1000 | Apr-31 | Bullet | 4,4 | 54 | FXD |
Ticker | Rating (M/S&P/F) | CPN | Size (m) | Mat | Call dt | Life | DM | CPN |
DANBNK | A1/A+/AA | 2,851 | 500 | May-28 | Bullet | 1,5 | 36 | FRN |
SHBASS | Aa2/AA-/AA+ | 3,116 | 750 | Feb-29 | Bullet | 2,2 | 37 | FRN |
INTNED | A2/A+/AA | 3,362 | 1250 | Nov-28 | Bullet | 2,0 | 50 | FRN |
CMZB | A2/A/- | 3,405 | 1250 | Nov-28 | Bullet | 2,0 | 57 | FRN |
IGC European Market: Deal Flow - General
Issuer | Term | Call | Coupon | Maturity | Size | Ranking | Type | Price | Spread | IPT-PXD |
|---|---|---|---|---|---|---|---|---|---|---|
S-Bank | 4NC3 | 3y | 3mE+130bp | 26-Nov-30 | €150m | SNP | Floating | 100 | 3mE+130 | -25 |
Reoffer: 4NC3: 3mE+130bp / 100
Final Books: Peak book above €320m (excl JLMs)
Launched: 4NC3: €150m @ 3mE+130bp - Books above €320m (excl JLMs)
Spread set at: 4NC3: 3mE+130bp
Guidance: 4NC3: 3mE+130+/-5bp WPIR - Books above €305m (incl €12m JLMs)
IPTs: 4NC3: 3mE+155a
COMPS | |||||
Security | Tenor/call | Amt (m) | Rating | Issued | Spread (bid) |
SPANOY Float 12/11/29 | 2.1y | 150 | /BBB | 11-Dec-25 | 113 (DM+) |
SBAB 3 3/8 05/21/31 | 3.5y | 500 | Baa1/BBB+ | 21-May-25 | 77 (I+) |
SYDBDC 3 5/8 05/29/31 | 3.5y | 500 | A3/ | 29-May-26 | 82 (I+) |
OPBANK 3 1/4 01/30/32 | 4.2y | 500 | Baa1/A | 30-Jan-26 | 91 (I+) |
SRBANK 3 3/4 04/21/32 | 4.4y | 500 | A3/ | 21-Apr-26 | 87 (I+) |
IGC European Market: Deal Flow - General
Issuer | Term | Coupon | Maturity | Size | Ranking | Type | Price | Yield | Spread | IPT-PXD |
|---|---|---|---|---|---|---|---|---|---|---|
American Medical Systems Europe B.V. | 2yr | 3mE+63 | 01-Dec-28 | €500m | Sr Unsec | Floating | 100 | - | 3mE+63 | -24.5 |
American Medical Systems Europe B.V. | 2yr | 3.875% | 01-Dec-28 | €500m | Sr Unsec | Fixed | 99.87 | 3.944% | MS+53 | -24.5 |
American Medical Systems Europe B.V. | 4yr | 4.125% | 01-Dec-30 | €750m | Sr Unsec | Fixed | 99.852 | 4.166% | MS+75 | -30 |
American Medical Systems Europe B.V. | 8yr | 4.5% | 01-Dec-34 | €750m | Sr Unsec | Fixed | 99.835 | 4.525% | MS+110 | -27.5 |
American Medical Systems Europe B.V. | 12yr | 4.75% | 01-Dec-38 | €1bn | Sr Unsec | Fixed | 99.275 | 4.831% | MS+135 | -27.5 |
American Medical Systems Europe B.V. | 20yr | 5.125% | 01-Dec-46 | €750m | Sr Unsec | Fixed | 99.3 | 5.182% | MS+170 | -30 |
Reoffer: 2yr FRN: 3mE+63bp / 100 2yr: MS+53bp / 99.87 / 3.944% 4yr: MS+75bp / 99.852 / 4.166% 8yr: MS+110bp / 99.835 / 4.525% 12yr: MS+135bp / 99.275 / 4.831% 20yr: MS+170bp / 99.3 / 5.182%
Benchmark: 2yr: OBL 2.4 Oct-28 #188 @ 98.545 / B+74.6bp (HR: 105%) 4yr: OBL 2.2 10-Oct-30 #192 @ 96.39 / B+96.3bp (HR: 103%) 8yr: DBR 2.6 15-Aug-34 @ 95.12 / B+120bp (HR: 101%) 12yr: DBR 1 May-38 @ 76.5 / B+130.6bp (HR: 112%) 20yr: DBR 2 ½ 15-Aug-46 @ 82.79 / B+143.3bp (HR: 100%)
Tranche 1 (2yr FRN): Final Books >€1.4bn. Peak book >€1.4bn
Tranche 2 (2yr FXD): Final Books >€1.6bn. Peak book greater than €1.8bn
Tranche 3 (4yr): Final Books >€2.2bn. Peak book greater than €2.9bn
Tranche 4 (8yr): Final Books >€2.5bn. Peak book greater than €3.2bn
Tranche 5 (12yr): Final Books >€2.6bn. Peak book greater than €3.1bn
Tranche 6 (20yr): Final Books >€1.7bn. Peak book greater than €2.7bn
Hedge Deadline: 15:45 UKT / 16:45 CET
Launched:
2yr FRN: €500m @ 3mE+63bp - Books greater than €1.3bn
2yr: €500m @ MS+53bp - Books greater than €1.8bn
4yr: €750m @ MS+75bp - Books greater than €2.9bn
8yr: €750m @ MS+110bp - Books greater than €3.2bn
12yr: €1bn @ MS+135bp - Books greater than €3.1bn
20yr: €750m @ MS+170bp - Books greater than €2.7bn
(Combined Books in excess of €15bn)
IPTs: 2yr FRN: 3mE+85/90bp 2yr: MS+75/80bp 4yr: MS+105a 8yr: MS+135/140bp 12yr: MS+160/165bp 20yr: MS+200a
2yr (Dec 2029) @ 3mE+85-90
Implied Spread for fresh 2yr @ 3mE+55
Priced at 3mE+63
NIC of +8
2yr (Dec 2028) @ MS+75-80
Implied Spread for fresh 2yr @ MS+45
Priced at MS+53
NIC of +8
4yr (Dec 2030) @ MS+105a
Implied Spread for fresh 4yr @ MS+70
Priced at MS+75
NIC of +5
8yr (Dec 2034) @ MS+135-140
Implied Spread for fresh 8yr @ MS+105
Priced at MS+110
NIC of +5
12yr (Dec 2038) @ MS+160-165
Implied Spread for fresh 12yr @ MS+125
Priced at MS+135
NIC of +10
20yr (Dec 2046) @ MS+200a
Implied Spread for fresh 20yr @ MS+160
Priced at MS+170
NIC of +10
COMPS | |||||
A Rated Med-Tech | |||||
Bond | Rating (M/S&P/F) | Issue Dt. | Amt | Tenor | I-spread |
BSX 1.375 3/28 | A3 / A- / A- | Mar-22 | €750mm | 1.3yr | ms+38bp |
BSX 3.375 3/29 | A3 / A- / A- | Feb-24 | €750mm | 2.3yr | ms+51bp |
BSX 3.000 3/31 | A3 / A- / A- | Feb-25 | €850mm | 4.3yr | ms+70bp |
BSX 1.625 3/31 | A3 / A- / A- | Mar-22 | €750mm | 4.3yr | ms+67bp |
BSX 3.500 3/32 | A3 / A- / A- | Feb-24 | €1250mm | 5.3yr | ms+80bp |
BSX 3.250 3/34 | A3 / A- / A- | Feb-25 | €650mm | 7.3yr | ms+97bp |
BSX 1.875 3/34 | A3 / A- / A- | Mar-22 | €500mm | 7.3yr | ms+91bp |
DHR 0.750 9/31 | A2 / A- / - | Sep-19 | €1750mm | 4.8yr | ms+55bp |
DHR 3.625 4/34 | A2 / A- / - | Apr-26 | €750mm | 7.5yr | ms+78bp |
DHR 4.000 4/38 | A2 / A- / - | Apr-26 | €1000mm | 11.5yr | ms+96bp |
DHR 1.800 9/49 | A2 / A- / - | Sep-19 | €750mm | 22.9yr | ms+129bp |
MDT 3.650 10/29 | A3 / A / - | Jun-24 | €850mm | 2.9yr | ms+38bp |
MDT 2.950 10/30 | A3 / A / - | Sep-25 | €750mm | 3.9yr | ms+48bp |
MDT 3.875 10/36 | A3 / A / - | Jun-24 | €850mm | 9.9yr | ms+81bp |
MDT 4.150 10/43 | A3 / A / - | Jun-24 | €600mm | 16.9yr | ms+131bp |
MDT 4.200 10/45 | A3 / A / - | Sep-25 | €750mm | 18.9yr | ms+141bp |
SYK 3.375 9/32 | A3 / BBB+ / - | Sep-24 | €800mm | 5.8yr | ms+71bp |
SYK 3.625 9/36 | A3 / BBB+ / - | Sep-24 | €600mm | 9.8yr | ms+91bp |
TMO 3.628 12/35 | A2 / A- / A- | Dec-25 | €1100mm | 9.0yr | ms+81bp |
TMO 1.875 10/49 | A2 / A- / A- | Sep-19 | €1000mm | 22.9yr | ms+138bp |
TMO 2.000 10/51 | A2 / A- / A- | Oct-21 | €750mm | 24.9yr | ms+137bp |
Other Recent Healthcare | |||||
Bond | Rating (M/S&P/F) | Issue Dt. | Amt | Tenor | I-spread |
GSK 3.500 9/30 | A2 / A / - | Sep-26 | €1000mm | 3.8yr | ms+51bp |
GSK 3.875 9/34 | A2 / A / - | Sep-26 | €850mm | 7.8yr | ms+76bp |
GSK 4.125 9/37 | A2 / A / - | Sep-26 | €800mm | 10.8yr | ms+96bp |
MRKGR 3.875 5/31 | A3 / A / - | Nov-26 | €900mm | 4.5yr | ms+58bp |
MRKGR 4.125 11/33 | A3 / A / - | Nov-26 | €1050mm | 7.0yr | ms+78bp |
MRKGR 4.250 11/36 | A3 / A / - | Nov-26 | €1050mm | 10.0yr | ms+97bp |
Healthcare FRNs | |||||
Bond | Rating (M/S&P/F) | Issue Dt. | Amt | Tenor | Spread |
DHR FRN 4/28 | A2 / A- / - | Apr-26 | €500mm | 1.4yr | 3mE+36bp |
GSK FRN 3/28 | A2 / A / - | Sep-26 | €850mm | 1.3yr | 3mE+31bp |
MRKGR FRN 11/28 | A3 / A / - | Nov-26 | €700mm | 2.0yr | 3mE+43bp |
TMO FRN 12/27 | A2 / A- / A- | Dec-25 | €1000mm | 1.0yr | 3mE+35bp |
To view the LIVE / REAL TIME European IG pipeline please click here.
Details correct at time of posting